NadimSalomonMDFISA

PubMed

• 150 citations
  Multidrug-Resistant Tuberculosis in Patients without HIV Infection
  Edward E. Telzak, Kent A. Sepkowitz, Peter Alpert, Sharon B. Mannheimer, Franz Medard
  The New England Journal of Medicine. 1995-10-05
• 89 citations
  Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis
  Wafaa El-Sadr, David C. Perlman, John P. Matts, Eileen T. Nelson, David L. Cohn
  Clinical Infectious Diseases. 1998-05-01
• 73 citations
  Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A R...
  Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou
  JAMA. 2022-02-01

Books/Book Chapters

• Sexually Transmitted Infections: Diagnosis, Management, and Treatment. 
  Chapter: Sexually Transmitted Diseases in Drug Users. 
  Perlman DC, Hagan H, Kottiri B, Salomon N, Friedman SREditors: Zenilman J and Shahmanesh M.Jones & Bartlet2011

Abstracts/Posters

• Using Electronic Chart Documentation to increase HIV Test Offering and Possible Detection of diseases.
  Dahlia Rizk , Scott Barnett , Charlene Monaco , Nadim Salomon, Journal of Hospital Medicine, 5/1/2013
• High Rate of Virologic Suppression at an Inner City HIV Clinic: Factors Associated with Virologic Suppression.
  Gweneth M. Francis, DO, Tessa Gomez, MD and Nadim Salomon, MD, 50th 44th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 12/1/2012
• Hospitalists' Critical Role in Public Health: Tackling HIV awareness with inpatient health educators.
  D. Rizk, DO, C. Monaco, S. Barnett, N. Salomon, SHM, Dallas, TX, 5/1/2010
• Phosphodiesterase inhibitor use among HIV infected patients in an urban HIV Clinic.
  Norton BL, Salomon N, Friedmann P, Perlman DC, XVII International AIDS Conference, Mexico City, 8/4/2008
• Seroconversion rates to hepatitis b vaccination among HIV infected persons
  Pang X, Perlman DC, Friedmann P, Salomon N, 45th Annual Meeting of the Infectious Diseases Society of America, 1/1/2007
• Predictors of Incident Sexually Transmitted Diseases in an Urban HIV Clinic.
  Yusuff J, Perlman DC, Friedmann P, Carey J, Salomon N, 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, 10/12/2006
• Clinical, virologic and immunologic outcomes of highly resistant HIV1 infection among ARV experienced patients.
  Philips, D, Perlman DC, Salomon N, 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Canada, 10/12/2006
• Prevalence and extent of highly resistant HIV infection among ARV experienced patients.
  Goldshteyn N, Salomon N, Rudominer R, Perlman DC, 43rd Annual Meeting of the Infectious Diseases Society of America, Session 92-HIV:RX, San Francisco, CA, 10/6/2005
• Self-reported sexual risk behaviors among HIV-infected patients attending four New York City HIV clinics.
  Murrill C, Beatty M, Raj-Singh S, Buckley L, Gurtman A, Sian J. Liu KL, Torian L and the Centers for Disease Control, the New York City Department of Health and Clini..., 12th Conference on Retrovirus and Opportunistic Infections, Boston, MA, 2/22/2005
• Outcome of patients with tuberculous meningitis in New York City (NYC) 1992-2001.
  Kentaro I, Sonal M, Osaman S, Kambili C, Driver C, Raucher B, Salomon N, Mizuta M, Hongo I, 41st Annual Meeting of the Infectious Diseases Society of America, New York, NY, 10/9/2003
• High rate of annual tuberculin skin test conversion in an HIV-infected population.
  Kadlecik PM, Salomon N, Friedmann P, Gomez T, Perlman DC, 41st Annual Meeting of the Infectious Diseases Society of America, 10/9/2003
• Access to health care services among drug users (Dus) attending a syringe exchange program (SEP) in New York City.
  Perlman DC, Horn L, Nugent A, Perason-Braff S, Salomon N, Friedmann P, Masson CL, Des Jarlais DC, 129th annual American Public Health Association Annual Meeting, Atlanta, GA, 10/25/2001
• Assessing readiness to enter drug abuse treatment among participants at a syringe exchange program.
  Perlman DC, Trinh C, Nugent A, Horn L, Friedmann P, Salomon N., Des Jarlais DC, American Public Health Association Annual Meeting, Boston, MA, 11/15/2000
• Individual level patterns of syringe exchange use.
  Perlman DC, Trinh C, Friedmann P, Nugent A, Horn L, Salomon N, Kramer D, Des Jarlais DC, American Public Health Association Annual Meeting, Boston, MA, 11/15/2000
• Balancing individual rights and societal interests: tuberculosis prevention policies for active substance users.
  Trinh C, Perlman DC, Bayer R, Northridge ME, Salomon N, Des Jarlais DC, American Public Health Association Annual Meeting, Boston, MA, 11/14/2000
• Retention in syringe exchange and the potential for longitudinal health care interventions at syringe exchange program.
  Perlman DC, Trinh C, Friedmann P, Horn L, Salomon N, Des Jarlais DC, Addictions 2000 Conference, Hyannis, Cape Cod, MA, 9/22/2000
• Expanding health care services at syringe exchange programs.
  Perlman DC, Trinh C, Horn L, Salomon N, Des Jarlais DC, Harm Reduction Conference, Miami, FL, 9/22/2000
• Assessing readiness to enter drug abuse treatment among participants at a syringe exchange program.
  Perlman DC, Thrinh C, Horn L, Nugent A, Friedmann P, Salomon N, Des Jarlais DC, College on Problems of Drug Dependence 62nd Annual Scientific Meeting, PR, 6/22/2000
• Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe exchange.
  Perlman DC, Gourevitch MN, Trinh C, Horn L, Des Jarlais DC, Salomon N, American Society for Microbiology Conference.: "Tuberculosis: Past, Present, and Future", New York, NY, 6/20/2000
• Cost-effectiveness of tuberculosis screening and observed therapy fro drug injectors at a syringe exchange.
  Perlman DC, Gourevitch M, Salomon N, College on Problems of Drug Dependence 60th Annual Scientific Meeting, Scottsdale, AZ, 6/1/1998
• Intermittent short course therapy for the treatment of HIV-related pulmonary tuberculosis: a prospective randomized trial in the U.S.
  El Sadr WM, Perlman DC, Matts J, Nelson E, Cohn D, Salomon N, Olibrice M, Telzak EE, Jones B, Hafner R and the Community Programs for Clinical Research on AIDS (CPPCRA..., American Thoracic Society Meeting, 5/1/1998
• G-CSF/GM-CSF do not improve outcome in neutropenic HIV patients.
  Ambati BK, Perlman DC, Salomon N, 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 2/1/1998
• TB screening and preventive therapy at a syringe exchange: an extension of harm reduction.
  Perlman DC, Salomon N, Perkins MP, Ziluck V, Friedmann P, Paone D, Lugo W, Ojeda L, Des Jarlais DC, Conference on Harm Reduction in Clinical Practice, John Jay College of Criminal Justice, New York, NY, 10/24/1997
• Durable remission after successful treatment of multidrug-resistant tuberculosis.
  Telzak EE, Sepkowitz K, Medard F, Alpert P, Blum S, Salomon N, Turrett G, 35th IDSA Annual Meeting, San Francisco, CA, 9/1/1997
• Tuberculosis directly observed preventive therapy for active drug users in two settings.
  Perlman DC, Salomon N, Garcia de Soria V, Perkins MP, Lugo W, Ojeda L, Friedmann P, Des Jarlais DC, Paone D, College on Problems of Drug Dependence 58th Annual Scientific Meeting, Nashville, TN, 6/1/1997
• Join now to see all

Lectures

• HIV and aging. 
  Marriott Hotel, La Guardia, NY - 1/11/2014
• Tuberculosis screening at entry to drug detoxification. 
  Scottsdale, AZ - 6/1/1998